17Indexed trials
mesh condition
Glioma
Intelligence
Glioma intelligence: 17 indexed trials, 4 recruiting studies, 14 sponsors across 10 countries.
4Recruiting
14Sponsors
10Countries
Leading sponsors
Duke University20 recruiting
Annick Desjardins20 recruiting
University of Texas Southwestern Medical Center20 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Eli Lilly and Company10 recruiting
Alliance for Clinical Trials in Oncology11 recruiting
Jose Carrillo10 recruiting
Leiden University Medical Center11 recruiting
Mayo Clinic11 recruiting
National Cancer Institute (NCI)10 recruiting
The Netherlands Cancer Institute11 recruiting
INSYS Therapeutics Inc10 recruiting
Geographic activity
United States13trials
Netherlands5trials
Canada2trials
France1trials
Austria1trials
Israel1trials
United Kingdom1trials
Germany1trials
Belgium1trials
China1trials
Leading interventions
Levetiracetam2trials
7 Tesla Scanning1trials
Carboplatin1trials
Abemaciclib1trials
Bevacizumab1trials
CCNU1trials
AZD74511trials
Cerebral open flow microperfusion1trials
Dexamethasone1trials
Enzastaurin (LY317615)1trials
IL13-PE38QQR1trials
3 Tesla scanning1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.